EP Patent

EP1460059A4 — Process for producing 5-(3-cyanophenyl)-3-formylbenzoic acid compound

Assigned to Teijin Ltd · Expires 2005-01-05 · 21y expired

What this patent protects

A 5-(3-cyanophenyl)-3-formylbenzoic acid compound represented by the general formula (IV) is obtained by reacting a 5-bromo-3-hydroxymethylbenzoic acid compound represented by the general formula (I) with manganese dioxide to prepare a 5-bromo-3-formylbenzoic acid compound repres…

USPTO Abstract

A 5-(3-cyanophenyl)-3-formylbenzoic acid compound represented by the general formula (IV) is obtained by reacting a 5-bromo-3-hydroxymethylbenzoic acid compound represented by the general formula (I) with manganese dioxide to prepare a 5-bromo-3-formylbenzoic acid compound represented by the general formula (II) and reacting the compound represented by the formula (II) with 3-cyanophenylboric acid represented by the formula (III) in the presence of a palladium complex. (IV) (I) (II) (III) (In the formulae, R is hydrogen or C1-10 alkyl.)

Drugs covered by this patent

Patent Metadata

Patent number
EP1460059A4
Jurisdiction
EP
Classification
Expires
2005-01-05
Drug substance claim
No
Drug product claim
No
Assignee
Teijin Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.